Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001567619-22-001167

Director bought 20,047 shares at an average $5.20 ($104,212)

From the SEC's structured data for this filing

Trades in this filing

Peyer James · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-01-11 Purchase : show line 1 in the form +10,845 $5.18 $56,177 4,940,258 I
2022-01-12 Purchase : show line 2 in the form +9,202 $5.22 $48,034 4,949,460 I
Open-market purchases · 20,047 sh · avg $5.20 · $104,212
Loading xslF345X03/doc1.xml…